Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function

被引：0
|
作者：
Hillary G. Caruso
Ryuma Tanaka
Jiyong Liang
Xiaoyang Ling
Aria Sabbagh
Verlene K. Henry
Tiara L. Collier
Amy B. Heimberger
机构：
[1] The University of Texas MD Anderson Cancer Center,Division of Pediatrics
[2] The University of Texas MD Anderson Cancer Center,Department of Neurosurgery
来源：
Journal of Neuro-Oncology | 2019年 / 145卷
关键词：
Chimeric antigen receptor T cell; Exhaustion markers; PD-1; PD-L1; LAG-3; TIM-3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 439
页数：10
相关论文
共 25 条
  • [1] Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function
    Caruso, Hillary G.
    Tanaka, Ryuma
    Liang, Jiyong
    Ling, Xiaoyang
    Sabbagh, Aria
    Henry, Verlene K.
    Collier, Tiara L.
    Heimberger, Amy B.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (03) : 429 - 439
  • [2] REDUCING THE EX VIVO MANUFACTURING TIME OF EGFRVIII-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS IMPROVES PHENOTYPE AND DEMONSTRATES POTENT ANTI-GLIOMA FUNCTION IN VIVO
    Tanaka, Ryuma
    Caruso, Hillary
    Ling, Xiaoyang
    Najjar, Amer
    Heimberger, Amy
    NEURO-ONCOLOGY, 2017, 19 : 116 - 116
  • [3] Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
    Abbott, Rebecca C.
    Verdon, Daniel J.
    Gracey, Fiona M.
    Hughes-Parry, Hannah E.
    Iliopoulos, Melinda
    Watson, Katherine A.
    Mulazzani, Matthias
    Luong, Kylie
    D'Arcy, Colleen
    Sullivan, Lucy C.
    Kiefel, Ben R.
    Cross, Ryan S.
    Jenkins, Misty R.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (05)
  • [4] EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma
    Miao, Hongsheng
    Choi, Bryan D.
    Suryadevara, Carter M.
    Sanchez-Perez, Luis
    Yang, Shicheng
    De Leon, Gabriel
    Sayour, Elias J.
    McLendon, Roger
    Herndon, James E., II
    Healy, Patrick
    Archer, Gary E.
    Bigner, Darell D.
    Johnson, Laura A.
    Sampson, John H.
    PLOS ONE, 2014, 9 (04):
  • [5] Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
    Ghassemi, Saba
    Nunez-Cruz, Selene
    O'Connor, Roddy S.
    Fraietta, Joseph A.
    Patel, Prachi R.
    Scholler, John
    Barrett, David M.
    Lundh, Stefan M.
    Davis, Megan M.
    Bedoya, Felipe
    Zhang, Changfeng
    Leferovich, John
    Lacey, Simon F.
    Levine, Bruce L.
    Grupp, Stephan A.
    June, Carl H.
    Melenhorst, J. Joseph
    Milone, Michael C.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09) : 1100 - 1109
  • [6] From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
    Pinto, E.
    Lione, L.
    Compagnone, M.
    Paccagnella, M.
    Salvatori, E.
    Greco, M.
    Frezza, V.
    Marra, E.
    Aurisicchio, L.
    Roscilli, G.
    Conforti, A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [7] Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma (vol 10, e1283, 2021)
    Abbott, Rebecca C.
    Verdon, Daniel J.
    Gracey, Fiona M.
    Hughes-Parry, Hannah E.
    Iliopoulos, Melinda
    Watson, Katherine A.
    Mulazzani, Matthias
    Luong, Kylie
    D'Arcy, Colleen
    Sullivan, Lucy C.
    Kiefel, Ben R.
    Cross, Ryan S.
    Jenkins, Misty R.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (07)
  • [8] 4-1BB costimulation ameliorates exhaustion and prolongs in vivo persistence of chimeric antigen receptor (CAR) expressing T cells
    Long, Adrienne H.
    Haso, Waleed M.
    Smith, Jillian P.
    Walker, Alec J.
    Fry, Terry J.
    Orentas, Rimas J.
    Mackall, Crystal L.
    CANCER RESEARCH, 2015, 75
  • [9] Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses
    Kuramitsu, S.
    Ohno, M.
    Ohka, F.
    Shiina, S.
    Yamamichi, A.
    Kato, A.
    Tanahashi, K.
    Motomura, K.
    Kondo, G.
    Kurimoto, M.
    Senga, T.
    Wakabayashi, T.
    Natsume, A.
    CANCER GENE THERAPY, 2015, 22 (10) : 487 - 495
  • [10] Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses
    S Kuramitsu
    M Ohno
    F Ohka
    S Shiina
    A Yamamichi
    A Kato
    K Tanahashi
    K Motomura
    G Kondo
    M Kurimoto
    T Senga
    T Wakabayashi
    A Natsume
    Cancer Gene Therapy, 2015, 22 : 487 - 495
123